Computed tomography-guided cryoablation in treating adrenal metastases: a retrospective single-center study

PURPOSE: To assess the effectiveness and safety of computed tomography (CT)-guided cryoablation for treating adrenal metastases (AMs). METHODS: This study included 12 patients treated with 13 CT-guided cryoablation procedures for AMs between 2016 and 2020. Patients were selected based on specific c...

Full description

Saved in:
Bibliographic Details
Main Authors: Claudio Pusceddu, Eliodoro Faiella, Claudio Cau, Pierluigi Rinaldi, Luca Melis, Salvatore Marsico
Format: Article
Language:English
Published: Galenos Publishing House 2025-07-01
Series:Diagnostic and Interventional Radiology
Subjects:
Online Access:https://www.dirjournal.org/articles/computed-tomography-guided-cryoablation-in-treating-adrenal-metastases-a-retrospective-single-center-study/doi/dir.2024.242956
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:PURPOSE: To assess the effectiveness and safety of computed tomography (CT)-guided cryoablation for treating adrenal metastases (AMs). METHODS: This study included 12 patients treated with 13 CT-guided cryoablation procedures for AMs between 2016 and 2020. Patients were selected based on specific criteria, including tumor size ≤5 cm and suitability for surgery. Procedures were performed by expert radiologists, with comprehensive monitoring for complications and regular post-treatment evaluations. RESULTS: The primary technical success rate was 91.7%, with a secondary success rate of 100% following repeat procedures. Over an 8–24-month follow-up period, local tumor recurrence was observed in 16.7% of patients, and systemic progression occurred in five (41.6%) patients. The average overall survival duration was 26.4 ± 5.6 months. CONCLUSION: CT-guided cryoablation is a feasible and effective treatment option for AMs, demonstrating high technical success rates and manageable complications. CLINICAL SIGNIFICANCE: This study highlights CT-guided cryoablation as a promising treatment for AMs, offering a minimally invasive alternative to surgery with good local control and safety profile. Further research, including multi-center studies, is needed to confirm these findings.
ISSN:1305-3825
1305-3612